-
The current polypharmacy management approach to chronic heart failure due to systolic dysfunction is of concern because it may lead to noncompliance
-
Surgical aortic valve replacement (avr) remains the gold standard treatment for patients with severe aortic stenosis (AS). However, a number of patients are at increased risk of mortality during AVR due to advanced age or co-morbidities.
-
Heart failure with normal left ventricular (LV) systolic function is thought to be due to diastolic dysfunction in most cases, but confirming LV diastolic dysfunction by echo Doppler techniques is often challenging.
-
These investigators describe the results of once a week rosuvastatin in 10 patients intolerant to once-a-day statins due to myalgias, high liver function tests and gastrointestinal side effects.
-
Aliskiren is a new class of drugs that directly inhibit renin and is approved in the U.S.A. for the treatment of hypertension. Valsartan is the best selling antihypertensive medication in the world.
-
This report describes a large group of patients with hypertrophic cardiomyopathy (HCM) who underwent implantable cardioverter defibrillator (ICD) implantation at 42 referral and nonreferral institutions in the United States, Europe and Australia.
-
Dalal and his colleagues describe data from the Johns Hopkins Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) registry concerning the efficacy of catheter ablation for ventricular tachycardia (VT) in this condition.
-
The increasing use of 64-slice computed tomography or MSCT is beginning to significantly impact the medical literature.
-
Patients with peripheral artery disease are at high risk for cardiovascular complications. Antiplatelet drugs are routinely prescribed for these patients, but is adding an oral anticoagulant of value?
-
